Bouchlarhem Amine, Merimi Ihssane, Bazid Zakaria, Ismaili Nabila, El Ouafi Noha
Faculty of Medicine and Pharmacy, Mohammed Ist University, Oujda, Morocco.
Department of Cardiology, Mohammed VI University Hospital Mohammed I University, Oujda, Morocco.
Clin Med Insights Cardiol. 2024 Sep 28;18:11795468241282855. doi: 10.1177/11795468241282855. eCollection 2024.
The debate remains open as to the difference in prevalence of mortality and occurrence of acute events in patients with Myocardial infarction with non-obstructive coronary arteries (MINOCA) and others with Myocardial infarction with coronary arteries disease (MI-CAD).
We conducted a 2-year retrospective study for patients admitted for Acute coronary syndrome (ACS) to analyze the clinical and prognostic characteristics of patients with MINOCA versus MI-CAD. We defined 1-year all-cause mortality as the primary outcome, and the secondary outcome as a composite of 1-year readmission for myocardial infarction or acute heart failure (AHF).
Our study included 1077 patients, 95.3% with MI-CAD and 4.7% with MINOCA. At admission, 71.1% patient were diagnosed STEMI and 28.9% with NSTEMI. The difference between the 2 groups was found on age ( < .001), hypertension, diabetes with consecutive -values of .007 and .001, as well as Ejection fraction ( < .001). For the outcomes studied, the difference was significant between the 2 groups for all events, and MINOCA patients had a better prognosis than MI-CAD patients, with adjusted hazard ratios (HR) for 1-year mortality (HR = 0.601 = .004), for readmission for ACS (HR = 0.662; = .002) and for readmission for AHF (HR = 0.539; = .019).
Despite the ambiguity in the genesis of MINOCA, the short- and long-term prognosis of these patients remains generally favorable.
关于非阻塞性冠状动脉心肌梗死(MINOCA)患者与冠状动脉疾病心肌梗死(MI-CAD)患者的死亡率及急性事件发生率的差异,目前仍存在争议。
我们对因急性冠状动脉综合征(ACS)入院的患者进行了一项为期2年的回顾性研究,以分析MINOCA患者与MI-CAD患者的临床及预后特征。我们将1年全因死亡率定义为主要结局,将心肌梗死或急性心力衰竭(AHF)1年再入院的复合情况定义为次要结局。
我们的研究纳入了1077例患者,其中95.3%为MI-CAD患者,4.7%为MINOCA患者。入院时,71.1%的患者被诊断为ST段抬高型心肌梗死(STEMI),28.9%为非ST段抬高型心肌梗死(NSTEMI)。两组在年龄(P<0.001)、高血压、糖尿病方面存在差异,连续变量的P值分别为0.007和0.001,以及射血分数(P<0.001)。对于所研究的结局,两组在所有事件上均存在显著差异,MINOCA患者的预后优于MI-CAD患者,1年死亡率的调整风险比(HR)为(HR = 0.601,P = 0.004),ACS再入院的HR为(HR = 0.662;P = 0.002),AHF再入院的HR为(HR = 0.539;P = 0.019)。
尽管MINOCA的发病机制尚不明确,但这些患者的短期和长期预后总体上仍然良好。